You searched for "regulation"
OXSIGHT Onyx – A sight-enhancing wearable
The Onyx is a newly-released (late 2021) wearable with a powered magnifier to assist those with central vision impairment. Unlike the previously covered wearable devices, this enhances existing sight. The unit can either be held against the eyes when needed,...Under pressure: a tool to aid the non-ophthalmic practitioner in the timely management of acute angle closure
Acute angle closure is a true ophthalmic emergency that mandates timely diagnosis and treatment. The priority in initial management is to lower the intraocular pressure in an expeditious matter using medical treatments. The risk of irreversible glaucomatous optic neuropathy is...
Use of control scores for intermittent exotropia
This study surveyed paediatric ophthalmologists to determine their use of the Newcastle, PEDIG and LACTOSE control scores in the diagnosis and management of intermittent exotropia. The authors aimed to identify how frequently control scores are used clinically, the barriers to...Intravitreal injections delivered by ophthalmic clinical nurse specialists
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...Commonwealth nations join forces to prevent blindness from diabetes
More than 70 representatives from 10 Commonwealth countries (in the African, Caribbean and Pacific regions) and Indonesia gathered at a five-day workshop in November 2014 to establish district or national plans to reduce blindness from diabetic retinopathy (DR). The event...
Risk of intraocular haemorrhage with new oral anticoagulants
The authors conducted a study to assess the risk of intraocular haemorrhage with warfarin dabigatran, rivaroxaban, apixaban. All reported cases of intraocular haemorrhage (vitreous, choroidal, or retinal) with warfarin and new oral anticoagulants (NOACs) (including dabigatran, rivaroxaban, apixaban) from the...Is lens constant optimisation for IOLMaster indispensable in order to achieve a good refractive outcome?
A study of refractive outcomes following cataract surgery was carried out with the aim of comparing the postoperative refractive outcomes against Royal College of Ophthalmologists standards and to determine the extent of association between accuracy of intraocular lens (IOL) power...
